Edition:
United States

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

10.06USD
18 Jul 2018
Change (% chg)

$-0.23 (-2.24%)
Prev Close
$10.29
Open
$10.30
Day's High
$10.44
Day's Low
$9.71
Volume
35,756
Avg. Vol
38,118
52-wk High
$17.54
52-wk Low
$7.45

Latest Key Developments (Source: Significant Developments)

Corvus Pharmaceuticals Announces Closing Of Public Offering Of Common Stock
Monday, 12 Mar 2018 09:15am EDT 

March 12 (Reuters) - Corvus Pharmaceuticals Inc ::CORVUS PHARMACEUTICALS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK.  Full Article

Corvus Pharmaceuticals reports third quarter 2017 financial results
Thursday, 2 Nov 2017 04:10pm EDT 

Nov 2 (Reuters) - Corvus Pharmaceuticals Inc ::Corvus Pharmaceuticals reports third quarter 2017 financial results and clinical program update.Net loss for three months ended September 30, 2017, was $12.7 million compared to $10.3 million for same period in 2016​.  Full Article

Corvus Pharma qtrly loss per share $0.43
Thursday, 4 Aug 2016 04:10pm EDT 

Corvus Pharmaceuticals Inc : Corvus pharmaceuticals announces second quarter financial results and provides business update . Q2 earnings per share view $-0.36 -- Thomson Reuters I/B/E/S .Qtrly loss per share $0.43.  Full Article

BRIEF-Corvus Pharmaceuticals Q1 Loss Per Share $0.63

* CORVUS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE